Choice of Inhalation Device
NCT05264441 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140
Last updated 2022-03-03
Summary
In this study, asthma and COPD patients will be invited to participate after the consultation with their pulmonologist.
The intervention consists of three steps. The first step is to perform a deep inspiration. The second step is to demonstrate the correct use of a pMDI. The third step is to perform a strong inspiration into the In-Check Dial device over 5 different resistances.
Conditions
Interventions
- DEVICE
-
In-Check DIAL G16
Patients will inspire into an In-Check DIAL G16 device.
Sponsors & Collaborators
-
Universitair Ziekenhuis Brussel
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-04-01
- Primary Completion
- 2022-05-01
- Completion
- 2023-06-01
More Related Trials
-
Study to Assess the Effect of Formoterol and Beclomethasone Dipropionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT01204034 ·Status: COMPLETED ·Phase: PHASE3
-
Lung Deposition of the BDP/Formoterol Combination Administered Via the NEXT DPI in Healthy, Asthmatic and COPD Patients
NCT01176747 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pharmacokinetics of CHF 5993 pMDI With and Without Spacer in COPD Patients
NCT02119234 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment Of The Inhalation Profiles Of Four Dry Powder Inhalers In Patients With Variable Degrees Of Lung Obstruction
NCT01033669 ·Status: COMPLETED
-
Breathing Parameter Measurements for Lung Deposition Simulation
NCT05445349 ·Status: COMPLETED
-
A Study to Evaluate the Effectiveness and Safety of CNTO6785 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
NCT01966549 ·Status: COMPLETED ·Phase: PHASE2
-
Validation of Questionnaire and Assessment of Patient Satisfaction for Budesonide/Formoterol Fix Combination Dry Powder Inhalers (DPI) in Chronic Obstructive Pulmonary Disease (COPD)
NCT01646424 ·Status: COMPLETED
-
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
NCT01867762 ·Status: COMPLETED ·Phase: PHASE2
-
A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation
NCT01712516 ·Status: COMPLETED ·Phase: PHASE3
-
Postmarketing Surveillance Study of Berodual® Metered-dose Inhaler in Chronic Obstructive Airways Disease
NCT02231424 ·Status: COMPLETED
-
Dose Ranging Study of Ba 679 BR Inhalation Powder in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT02172352 ·Status: COMPLETED ·Phase: PHASE2
-
The Asthma Bronchial Challenge Study
NCT03575663 ·Status: COMPLETED
-
Inhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD)
NCT01721291 ·Status: COMPLETED ·Phase: PHASE4
-
Peak Inspiratory Flow and Dry Powder Inhaler Performance in COPD
NCT04606394 ·Status: COMPLETED ·Phase: PHASE4
-
Nebulizer Versus Dry Powdered Inhalers for Chronic Obstructive Pulmonary Disease (COPD)
NCT03219866 ·Status: TERMINATED ·Phase: PHASE4
-
PT003 MDI Dose Confirmation Study
NCT01349816 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating Preference, Satisfaction And Correct Use Of Inhalers In COPD Patients
NCT01727024 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluate the Effects of Formoterol and Beclomethasone Dipropionate Combination Therapy on Small Airways Function
NCT01466712 ·Status: UNKNOWN ·Phase: PHASE4
-
Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary Disease
NCT01019694 ·Status: COMPLETED ·Phase: PHASE3
-
Sensitivity of the Step Test to Detect Improvement in Dyspnea Following Bronchodilation in Patients With Chronic Obstructive Pulmonary Disease
NCT01655199 ·Status: UNKNOWN ·Phase: NA
-
PASS to Assess Cardiovascular and Cerebrovascular Events in COPD Patients Initiating Fixed Triple Therapy (DPI or pMDI)
NCT05652439 ·Status: RECRUITING
-
The International Nocturnal Oxygen (INOX) Trial
NCT01044628 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetic Pilot Study on Budesonide/Formoterol
NCT01457716 ·Status: COMPLETED ·Phase: NA
-
Comparative Study on Usability of Inhaler Devices in Adults With Asthma or COPD
NCT02757209 ·Status: COMPLETED ·Phase: NA
-
Formoterol Via pMDI HFA-134a Propellant or DPI in Partially Reversible Chronic Obstructive Pulmonary Disease (COPD)
NCT00742248 ·Status: COMPLETED ·Phase: PHASE2